Neil Kumar
Chief executive of BridgeBio who appears to discuss the company's recent Phase 3 wins, regulatory plans, and the firm's hub-and-spoke strategy.
Best podcasts with Neil Kumar
Ranked by the Snipd community
11 snips
Oct 30, 2025 • 38min
376: BridgeBio’s great week and Moderna’s unraveling
Neil Kumar, the CEO of BridgeBio, shares insights about the company's recent Phase 3 successes and discusses their innovative hub-and-spoke model. He reveals exciting news about the potential full approval for Ripetol and competitive strategies for Atrubi. Meanwhile, STAT reporter Jason Mast dives into Moderna's post-COVID turmoil, examining internal conflicts and the fallout from ambitious expansions. He highlights the challenges ahead for mRNA technology in therapeutics and the impact of political sentiment on the company’s future.
10 snips
Nov 20, 2025 • 1h 13min
Ep190: Neil Kumar on Building a Rare Disease Drug Company
Neil Kumar, the visionary Founder and CEO of BridgeBio Pharma, dives into the complexities of developing drugs for rare diseases. He shares insights on the unique challenges of venture funding in this space and explains BridgeBio's innovative hub-and-spoke model that optimizes asset selection and team focus. Neil reflects on the lessons learned from his journey, including the significance of a patient-driven approach and adapting to setbacks. Above all, he emphasizes the importance of a diverse portfolio to balance risks while nurturing groundbreaking therapies.
